Aldosterone and Treatment-Resistant Hypertension
Jane A. Leopold, Julie R. Ingelfinger
Abstract
Components of the renin–angiotensin–aldosterone pathway are targets for drugs to control resistant hypertension. This editorial describes a new drug targeting aldosterone synthase.
Topics & Concepts
MedicineAldosteroneResistant hypertensionInternal medicineHyperaldosteronismIntensive care medicineEndocrinologyCardiologyBlood pressureHormonal Regulation and HypertensionBlood Pressure and Hypertension StudiesEicosanoids and Hypertension Pharmacology